Mehtap BOZKURT, Ramazan GÜN, Ali GÜR, Demet UÇAR, KEMAL NAS

Romatoid artritli hastalarda sensörinöral işitme kaybı

Amaç: Romatoid artrit (RA)’li hastalarda işitme kaybı oranını, tipini ve mevcut kaybın kontrol grubuna göre farklı olup olmadığını araştırmak. Gereç ve yöntem: Çalışmaya 50 RA hastası ve 34 sağlıklı kontrol grubu alındı. Her iki gruptakilere; 250-8.000 Hz frekanslar arasında pür tone odyometri, stapes refleksi ve Oto Akustik Emisyon testi yapıldı. Bulgular: Olguların yaş ortalaması RA’lı hastalarda 36,88 ± 8,81 yıl ve kontrol grubunda 35,58 ± 8,19 yıl olarak bulundu. Ortalama hastalık süresi RA’da 4,72 (0-21) yıl bulundu. RA’lı hastaların 10’ unda (%20) ve kontrol grubunun 3’ ünde (%8,8) işitme kaybı saptandı. İşitme kaybı açısından gruplar arasında istatistiksel olarak anlamlı bir fark bulunmadı (p=0,139). Romatoid artritli hastalarda %14 ve kontrol grubundakilerde %8,8 olmak üzere her iki grupta da en sık sensörinöral tip işitme kaybı (SNİK) bulundu. Hastalık süresi 10 yıldan fazla olan yedi RA’lı hastanın 6’sında (%85.7) işitme kaybı mevcuttu. Sonuç: Romatoid artrit ve kontrol grubu arasında işitme kaybı açısından anlamlı fark bulunmadı. RA’lı hastalarda hastalık süresi uzadıkça işitme kaybı görülme oranı artmaktadır.

Sensorineural hear-loss in patients with rheumatoid arthritis

Objectives: The aim of this study was to evaluate the rate and type of the hearing loss in patients with rheumatoid arthritis (RA); and to analyze whether these hearing loss rates were different from control group or not. Materials and methods: The study included 50 RA patients and 34 healthy control subjects. All two groups underwent, pure tone audiometric test between 250-8.000 Hz frequencies; stapes reflex test and otoacoustic emissions. Results: The mean ages were 36, 88 ± 8, 81 years in RA cases and 35, 58 ± 8, 19 years in control group. The mean disease duration was 4.72 (range 2-21) years in patients with RA. Hearing loss was detected in 10 (20%) of the RA patients and 3 (8.8%) of the control group. The difference between the groups was not statistically significant in terms of hearing loss (p=0,139). The sensorineural hearing loss was the most commonly detected hearing loss type. The distribution of this type of hearing loss was 14% in RA and 8.8% in control group. Hearing loss was present in 6 (85.7%) of the seven RA patients whose duration of the disease was more than 10 years. Conclusion: There was not found significant difference between RA and control group with respect to hearing loss. In RA cases, the degree of hearing loss was increasing with the duration of the diseases.

PDF

___

1. Takatsu M, Higaki M, Kinoshita H, Mizushima Y, Koizuka I. Ear involvement in patients with rheumatoid arthritis. Otol Neurotol 2005; 26(6):755-1.
2. Rigual NR. Otolaryngologic manifestations of rheumatoid arthritis. Ear Nose Throat J 1987; 66(1):18-22.
3. Coletti V, Fiorino FG, Bruni L, Biasi D. Middle ear mechanics in subjects with rheumatoid arthritis. Audiology 1997;36(2):136-46.
4. Frade C, Martin C. Diagnostic value of the multi-frequency tympanometry in active rheumatoid arthritis. Auris Nasus Larynx 1998; 25(2):131-6.
5. Ozcan M, Karakus MF, Gunduz OH, Tuncel U, Sahin H. Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int 2002; 22(1):16-9.
6. Reiter D, Konkle DF, Myers AR, Schimmer B, Sugar JO. Middle ear immittance in rheumatoid arthritis. Arch Otolaryngol 1980;106(1):114-7.
7. Elwany S, El Garf A, Kamel T. Hearing and middle ear function in rheumatoid arthritis. J Rheumatol 1986;13:878-81.
8. Kakani RS, Mehra YN, Deodhar SD, Kakani RS, Mehra YN. Audiovestibular functions in rheumatoid arthritis. J Otolaryngol 1990;19(1):100-2.
9. Jung TT, Rhee C-K, Lee C, Park YS, Choi DC. Ototoxicity of salicylate, nonsteroidal anti inflammatory drugs and quinine. Otolaryngol Clin North Am 1993;26(1):791-812.
10. Marioni G, Perin N, Tregnaghi A, Bellemo B, Staffieri A, de Filippis C. Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin. A treatment after renal transplantation for focal glomerulosclerosis. Acta Oto-Laryngol 2004; 124(5):603-7.
11. Toone E, Hayden D, Ellman H. Ototoxicity of chloroquine. Arthritis Rheum 1965; 8(4): 475-6.
12. Casellini C, Citera G, RosemVet M, Ruggeri S, Saviotti A, Maldonado Cocco JA. Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol 2005;11(1):81-5.
13. Gussen R. Atypical ossicle joint lesions in rheumatoid arthritis with sicca syndrome (Sjogren syndrome). Arch Otolaryngol 1977; 103(2):284-6.
14. Heyworth T, Liyanage SP: A pilot survey of hearing loss in patient with rheumatoid arthritis. Scand J Rheumatol 1972;1(1):81-3.
15. Kastanioudakis I, Skevas A, Danielidis V, Tsiakou E, Drosos AA, Moustopoulos MH. Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol 1995;109(6):713-8.
16. Magaro M, Zoli A, Altomonte L, et al. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol 1990; 8(7):487-90.
17. Öztürk A, Yalçın Ş, Kaygusuz İ, Şahin S, Gök Ü, Karlıdağ T, Ardıçoğlu Ö. High-Frequency Hearing Loss and Middle Ear Involvement in Rheumatoid Arthritis. Am J Otolaryngol 2004; 25(3): 411-7.
18. Dikici O, Muluk NB, Tosun AK, Ünlüsoy I. Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors aVecting hearing levels. Eur Arch Otorhinolaryngol 2009; 266(12): 1719-26.
19. Robinette M Clinical observations with transient otoacoustic emissions with adults. Semin Hear 1992; 13(1):23-36.
20. Bonfils P, Bertrand Y, Uziel A. Evoked otoacoustic emissions: normative data and presbyacusis. Audiology 1988;27(1):27-35.
21. Desai A, Reed D, Cheyne A Richards S, Prasher D. Absence of otoacoustic emissions in subjects with normal audiometric thresholds implies exposure to noise. Noise Health 1999;1(1):58-65.
22. Murdin L, Patel S, Walmsley J, Yeoh HL. Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol 2008; 27: 637-40.
23. İkiz AO, Unsal E, Kirkim G, Erdağ TK, Güneri EA. Hearing loss and middle ear involvement in patients with juvenil idiopathic arthritis. Int J Pediatric Otorhinolaryng 2007; 71(8):1079-85.
24. Copeman WSC: Rheumatoid otoarthritis. Br Med J 1963;2(12):1526-1527.
25. Goodwill CJ, Lord IJ, Jones RPK. Hearing in rheumatoid arthritis. Ann Rheum 1972; 31(2):170-3.
26. Gür A, Nas K, Çevik R, Erdoğan F, Denli A. The quality of life status of patients with rheumatoid arthritis and osteoarthritis. Dicle Tip Dergisi 2000; 1(1): 41-6.